Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals. If we consider the specifics of each trade, it is accurate to state that 9% of the investors ...

Vertex Pharmaceuticals secured European approval for Alyftrek, reinforcing its dominance in cystic fibrosis treatment as ...

Blind and visually impaired Middle Eastern motorsport fans will soon become more immersed in Formula E through an innovative, AI-powered, audio race rep ...

Vertex Pharmaceuticals is currently pushing against the $467.85 resistance level as its stock maintains an upward trend.

Formula E and Google Cloud have launched an AI-powered audio race report to make motorsport accessible to visually impaired ...